General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows

v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:                
Net (loss) income     $ (82,694,000) $ (66,411,000)   $ (135,896,000) $ (72,260,000) $ (161,470,000)
Adjustments to reconcile net income loss to net cash used in operating activities:                
Change in fair value of derivative warrant liabilities     (16,510,000) 0        
Transaction costs allocated to derivative liabilities upon Business Combination     6,673,000 0        
Remeasurement of convertible preferred stock warrant liability     (1,616,000) 1,308,000   1,234,000 964,000 430,000
Stock-based compensation     24,534,000 7,269,000   14,610,000 7,762,000 11,960,000
Depreciation and amortization     2,864,000 2,337,000   4,992,000 4,115,000 2,361,000
Non-cash interest expense     312,000 313,000   704,000 917,000 848,000
Gain on purchase of a business           0 0 (2,670,000)
Inventory reserve     1,693,000 1,719,000   4,725,000 1,820,000 349,000
Loss on extinguishment of debt     0 1,027,000   1,027,000 0 0
Other non-cash expenses     139,000 387,000   1,274,000 401,000 215,000
Changes in operating assets and liabilities:                
Accrued costs and expenses     525,000 7,327,000   (817,000) 5,582,000 (1,829,000)
Inventory     (734,000) (11,320,000)   (12,598,000) (18,611,000) (1,661,000)
Prepaids and other assets     613,000 (3,059,000)   (3,294,000) (1,437,000) (194,000)
Accounts payable     (3,495,000) (3,426,000)   (2,489,000) (16,250,000) 19,286,000
Deferred revenue     1,308,000 1,788,000   148,000 2,102,000 4,603,000
Operating lease right-of-use assets and liabilities     (52,000) 45,000   65,000 278,000 0
Other liabilities     302,000 (1,103,000)   (774,000) 961,000 2,967,000
Net cash used in operating activities     (66,138,000) (61,799,000)   (127,089,000) (83,656,000) (124,805,000)
Cash Flows from Investing Activities:                
Purchase of investments           0 0 (8,640,000)
Proceeds from maturities of investments           0 0 8,700,000
Purchase of property and equipment     (2,610,000) (2,845,000)   (5,768,000) (4,820,000) (10,744,000)
Purchase of intangible assets           0 0 (873,000)
Acquisition of a business           0 0 (750,000)
Net cash used in investing activities     (2,610,000) (2,845,000)   (5,768,000) (4,820,000) (12,307,000)
Cash flows from financing activities:                
Proceeds from issuance of common stock upon Closing of Business Combination     97,100,000 0        
Proceeds From Contingently Redeemable Convertible Common Stock     27,500,000 0        
Payment of offering costs     (1,267,000) (340,000)   (1,396,000) 0 0
Proceeds from issuance of convertible preferred stock, net of issuance costs           0 214,790,000 96,529,000
Proceeds from issuance of debt     0 25,000,000   60,000,000 43,513,000 17,172,000
Repayment of debt     (562,000) (21,165,000)   (21,932,000) (33,118,000) (6,029,000)
Payment of debt extinguishment     0 (2,499,000)   (2,499,000) 0 0
Payment of debt issuance costs     (211,000) (375,000)   (375,000) (279,000) (365,000)
Proceeds from exercise of stock options and warrants     237,000 525,000   1,209,000 3,264,000 140,000
Repurchase of common stock     (32,000) (297,000)   (297,000) 0 0
Net cash provided by financing activities     122,765,000 849,000   34,710,000 228,170,000 107,447,000
Net increase (decrease) in cash and cash equivalents     54,017,000 (63,795,000)   (98,147,000) 139,694,000 (29,665,000)
Cash and cash equivalents at beginning of year $ 78,376,000   78,376,000 176,523,000   176,523,000 36,829,000 66,494,000
Cash and cash equivalents at end of year     132,393,000 112,728,000 $ 78,376,000 78,376,000 176,523,000 36,829,000
Supplemental Cash Flow Information [Abstract]                
Cash paid for income taxes     61,000 52,000   52,000 4,000 1,000
Cash paid for interest     3,052,000 1,299,000   4,472,000 3,887,000 1,153,000
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]                
Transaction costs, convertible preferred stock and contingently redeemable convertible common stock issuance costs included in accounts payable and accrued liabilities     21,435,000 291,000        
Purchases of property and equipment included in accounts payable and accrued liabilities     122,000 139,000   112,000 86,000 408,000
Issuance of common stock for business and asset acquisitions             67,000 530,000
Deferred offering and convertible preferred stock issuance costs included in accounts payable and accrued liabilities           1,928,000 284,000  
Debt issuance costs recorded with an offset to convertible preferred stock warrant liability             323,000 374,000
Initial measurement of common stock warrants recorded as debt issuance costs     0 1,622,000   1,622,000    
Net exercise of preferred stock warrants     989,000 0        
Conversion of contingently redeemable convertible common stock and convertible preferred stock to common stock     516,365,000          
Assumption of derivative liabilities upon Business Combination     93,196,000,000          
Reclassification of Grove's preferred stock warrant liability to additional paid-in capital     2,182,000,000          
Vesting of early exercised stock options     125,000 $ 1,245,000   1,577,000 $ 68,000 $ 49,000
Virgin Group Acquisition Corp. II [Member]                
Cash flows from operating activities:                
Net (loss) income (23,552,197) $ (732,339)     2,698,369      
Adjustments to reconcile net income loss to net cash used in operating activities:                
Interest income on cash and investments held in Trust Account (35,883) (1,444)     (30,526)      
Offering costs allocated to derivative warrant liabilities 0 497,634     570,496      
Change in fair value of derivative warrant liabilities (7,654,280) 208,793     (6,811,133)      
Initial measurement of backstop derivative liability 30,234,314              
Changes in operating assets and liabilities:                
Prepaid assets 155,123 (1,244,423)     (770,439)      
Accrued costs and expenses 395,513 1,266,779     2,419,324      
Due to related party 30,000 0     1,667      
Net cash used in operating activities (427,410,000,000) (5,000,000,000)     (1,922,242,000,000)      
Cash Flows from Investing Activities:                
Investment of cash in Trust Account (402,500,000) (350,000,000)     (402,500,000)      
Net cash used in investing activities   (350,000,000)     (402,500,000)      
Cash flows from financing activities:                
Proceeds from purchase of Class B shares by initial shareholder 0 25,000     25,000      
Proceeds from initial public offering, net of underwriters' discount 0 343,000,000     394,450,000      
Proceeds from private placement 0 9,000,000     10,050,000      
Proceeds from notes payable—related party         1,000,000      
Payment of offering costs 0 (595,525)     (595,525)      
Net cash provided by financing activities   351,429,475     404,929,475      
Net increase (decrease) in cash and cash equivalents (427,410) 1,424,475     507,233      
Cash and cash equivalents at beginning of year 507,233 0 $ 507,233   0      
Cash and cash equivalents at end of year 79,823 1,424,475     507,233 $ 507,233    
Supplemental disclosure of cash flow information:                
Deferred underwriting commissions charged to temporary equity $ 0 $ 12,250,000     $ 14,087,500